216 related articles for article (PubMed ID: 11128359)
1. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance.
Buysschaert M; Dramais AS; Wallemacq PE; Hermans MP
Diabetes Care; 2000 Dec; 23(12):1816-22. PubMed ID: 11128359
[TBL] [Abstract][Full Text] [Related]
2. Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin.
Russo GT; Giandalia A; Romeo EL; Scarcella C; Gambadoro N; Zingale R; Forte F; Perdichizzi G; Alibrandi A; Cucinotta D
J Endocrinol Invest; 2016 Mar; 39(3):305-14. PubMed ID: 26233336
[TBL] [Abstract][Full Text] [Related]
3. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Ventura P; Panini R; Emiliani S; Salvioli G
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
[TBL] [Abstract][Full Text] [Related]
4. Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes.
Sato Y; Ouchi K; Funase Y; Yamauchi K; Aizawa T
Endocr J; 2013; 60(12):1275-80. PubMed ID: 24018893
[TBL] [Abstract][Full Text] [Related]
5. High plasma homocysteine concentrations are associated with plasma concentrations of thrombomodulin in patients with type 2 diabetes and link diabetic nephropathy to macroangiopathy.
Okumura K; Aso Y
Metabolism; 2003 Nov; 52(11):1517-22. PubMed ID: 14624417
[TBL] [Abstract][Full Text] [Related]
6. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
[TBL] [Abstract][Full Text] [Related]
7. The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes.
Davies L; Wilmshurst EG; McElduff A; Gunton J; Clifton-Bligh P; Fulcher GR
Diabetes Care; 2001 Oct; 24(10):1805-9. PubMed ID: 11574446
[TBL] [Abstract][Full Text] [Related]
8. Mild hyperhomocysteinemia and the common C677T polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes.
Russo GT; Di Benedetto A; Alessi E; Ientile R; Antico A; Nicocia G; La Scala R; Di Cesare E; Raimondo G; Cucinotta D
J Endocrinol Invest; 2006 Mar; 29(3):201-7. PubMed ID: 16682831
[TBL] [Abstract][Full Text] [Related]
9. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.
Wollesen F; Brattström L; Refsum H; Ueland PM; Berglund L; Berne C
Kidney Int; 1999 Mar; 55(3):1028-35. PubMed ID: 10027940
[TBL] [Abstract][Full Text] [Related]
10. Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study.
Schaffer A; Verdoia M; Barbieri L; Cassetti E; Suryapranata H; De Luca G
Ann Nutr Metab; 2016; 68(3):180-8. PubMed ID: 26950830
[TBL] [Abstract][Full Text] [Related]
11. Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia.
Aso Y; Yoshida N; Okumura K; Wakabayashi S; Matsutomo R; Takebayashi K; Inukai T
Clin Chim Acta; 2004 Oct; 348(1-2):139-45. PubMed ID: 15369747
[TBL] [Abstract][Full Text] [Related]
12. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes.
Emoto M; Kanda H; Shoji T; Kawagishi T; Komatsu M; Mori K; Tahara H; Ishimura E; Inaba M; Okuno Y; Nishizawa Y
Diabetes Care; 2001 Mar; 24(3):533-8. PubMed ID: 11289481
[TBL] [Abstract][Full Text] [Related]
13. Micro- and macrovascular complications and hyperhomocysteinaemia in type 1 diabetic patients.
Buysschaert M; Jamart J; Dramais AS; Wallemacq P; Hermans MP
Diabetes Metab; 2001 Dec; 27(6):655-9. PubMed ID: 11852373
[TBL] [Abstract][Full Text] [Related]
14. Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus.
Stabler SP; Estacio R; Jeffers BW; Cohen JA; Allen RH; Schrier RW
Metabolism; 1999 Sep; 48(9):1096-101. PubMed ID: 10484047
[TBL] [Abstract][Full Text] [Related]
15. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
[TBL] [Abstract][Full Text] [Related]
16. Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus.
Abdella NA; Mojiminiyi OA; Akanji AO; Moussa MA
Acta Diabetol; 2002 Dec; 39(4):183-90. PubMed ID: 12486492
[TBL] [Abstract][Full Text] [Related]
17. Plasma homocysteine and microvascular complications in type 1 diabetes.
Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
[TBL] [Abstract][Full Text] [Related]
18. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
[TBL] [Abstract][Full Text] [Related]
19. [Changes of plasma total homocysteine in type I diabetic patients its association with diabetic vascular complications].
Yu TT; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):980-4. PubMed ID: 19253841
[TBL] [Abstract][Full Text] [Related]
20. Impaired glucose tolerance (IGT) is not associated with disturbed homocysteine metabolism.
Pixa A; Pietzsch J; Julius U; Menschikowski M; Hanefeld M
Amino Acids; 2000; 18(3):289-98. PubMed ID: 10901625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
